Review: Results of Endolymphatic Sac Surgery Mixed in Meniere Disease
THURSDAY, Oct. 20, 2022 (HealthDay News) -- Endolymphatic sac surgery appears to offer mixed results for the treatment of Menière disease, according to a systematic review published online Oct. 8 in the European Archives of Oto-Rhino-Laryngology.
Franziska A. Szott, from Aachen University Hospital in Germany, and colleagues conducted a systematic review and meta-analysis to examine the treatment efficiency of endolymphatic sac surgery in patients with Menière disease.
The researchers found that according to American Academy of Otolaryngology-Head and Neck Surgery 85/95, the effect of 9.25 dB postoperative weighted average hearing loss in surgically treated individuals was classified as "clinically not significant." However, the 26.23 percent deterioration in speech comprehension was considered clinically significant. A two-category improvement of functional-level scale assessment, representing a category B assessment of vertigo control, was observed.
"Based on the results, it can be generally concluded that the therapy leads to evident functional level and vertigo improvement, with limitations to long-term follow-up for vertigo by considering a period of maximum two years, while a reduction in auditory abilities occurs," the authors write.
Related Posts
¿Dormir bien ayuda a las mujeres a avanzar en su carrera?
MIÉRCOLES, 2 de noviembre de 2022 (HealthDay News) -- Para las mujeres, la clave...
El humo de los incendios forestales podría provocar más de 9,000 muertes al año en EE. UU.
MARTES, 27 de junio de 2023 (HealthDay News) -- Las nubes de humo continúan...
AAP Updates Recommendations for Safe Infant Sleep Practices
TUESDAY, June 21, 2022 (HealthDay News) -- In a policy statement from the...
Hypertensive Disorders of Pregnancy Linked to Risk for CVD
FRIDAY, Feb. 24, 2023 (HealthDay News) -- Genetic evidence indicates that...